GeneXpert test cartridge being used to test a sample of suspected TB in MSF’s lab at Bangassou Hospital, Central African Republic, 2017.
Press release |

TB test price reduction by Cepheid and Danaher is an important step in the right direction

Cepheid and Danaher have just announced that they are reducing the price of the Xpert MTB/RIF test by 20% in high-TB-burden countries, from US$9.98 to $7.97 per test. This reduction is a significant step, considering the corporations have refused to reduce the price of this test for over ten years.

TUBERCULOSIS
Read more
Photo credit: Borja Ruiz Rodriguez/MSF

Latest news

Publications

Read, watch, share

What good is a breakthrough medicine if the people who need it can't afford it?

Video thumbnail
100 years of insulin
Video thumbnail
MSF International President appeals to governments blocking landmark COVID-19 proposal
Video thumbnail
COVID-19: No patents or profiteering in a pandemic
Video thumbnail
No monopolies - Access to COVID-19 treatment
Video thumbnail
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
Video thumbnail
A Snapshot of the Access Campaign
Lives over profit
20 Years of Advocacy in Action - JOIN US!

Our work

COVID-19
Drug-resistant infections
Diabetes
Hepatitis C
HIV/AIDS
Tropical & neglected diseases
Tuberculosis
Vaccines
Patents & intellectual property
Research & development